摘要 |
A liposomal pharmaceutical formulation comprising multivalent ionic drug, a process for the preparation thereof, and the use thereof in the treatment of diseases, wherein the particle size of the liposome is about 30-80 nm, and the phospholipid bilayer contains a phospholipid with Tm> body temperature thereby the phase transition of the liposome is above body temperature. |